The following represents disclosure information provided by authors of this abstract. The Breast Cancer Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The effect of molecular subtype on survival in a racially diverse cohort of patients with high-risk breast cancer receiving trimodality therapy.
J. L. Wright
No relevant relationships to disclose
C. Takita
No relevant relationships to disclose
J. E. Panoff
No relevant relationships to disclose
I. M. Reis
No relevant relationships to disclose
W. Zhao
No relevant relationships to disclose
V. Sujoy
No relevant relationships to disclose
C. G. Fernandez
No relevant relationships to disclose
M. Jorda
No relevant relationships to disclose
D. Franceschi
No relevant relationships to disclose
J. Hurley
No relevant relationships to disclose